1.Clinical analysis of 12 Korean Lambert-Eaton myasthenic syndrome (LEMS) patients.
Joon Shik MOON ; Il Nam SUNWOO ; Seung Min KIM ; Sang Ahm LEE ; Kwang Ho CHO ; Kee Duk PARK ; Woo Kyung KIM ; Byung Ok CHOI ; Hwa Young CHUN
Yonsei Medical Journal 1999;40(5):454-459
The Lambert-Eaton myasthenic syndrome (LEMS) heralds the occurrence of malignancy, especially small-cell lung cancer (SCLC), but it can also occur in the absence of cancer. Twelve patients were diagnosed as LEMS by clinical features and the classical electrophysiological triad, which includes a low amplitude of compound muscle action potentials (CMAP), decremental responses on low-rate stimulation, and incremental responses on high-rate stimulation on the repetitive nerve stimulation (RNS) test. There were 6 male and 6 female patients, ranging in age from 49 to 66 years. Malignancy(all were SCLC) was found in 7 patients. Males predominantly expressed the paraneoplastic form; whereas the primary autoimmune form was found only in women, who showed a good response to corticosteroid treatment. The neurological features were similar in both groups: proximal lower limb weakness, depressed muscle stretch reflexes, and dryness of mouth in nearly all patients. Bulbar dysfunction and limb paresthesia were a little more frequent in the paraneoplastic form. In RNS tests, the characteristic electrophysiological abnormalities were found in all patients and were more profound in the paraneoplastic form. We concluded that LEMS is commonly associated with malignancy, especially SCLC, but it should also be stressed that there are many female LEMS patients who do not harbor any malignancy at all, and that other treatment strategies such as immunotherapy should be considered for these patients.
Aged
;
Carcinoma, Small Cell/complications
;
Female
;
Human
;
Lambert-Eaton Myasthenic Syndrome/therapy
;
Lambert-Eaton Myasthenic Syndrome/physiopathology*
;
Lung Neoplasms/complications
;
Male
;
Middle Age
;
Paraneoplastic Syndromes/physiopathology
2.A Case of Uterine Cervical Cancer Presenting with Granulocytosis.
Heui June AHN ; Yeon Hee PARK ; Yoon Hwan CHANG ; Sun Hoo PARK ; Min Suk KIM ; Baek Yeol RYOO ; Sung Hyun YANG
The Korean Journal of Internal Medicine 2005;20(3):247-250
Granulocytosis occurs in 40% of patients with lung and gastrointestinal cancers, 20% of patients with breast cancer, 30% of patients with brain tumor and ovarian cancer and 10% of patients with renal cell carcinoma. Granulocytosis occurs because of production of G-CSF, GM-CSF and IL-6. Uterine cervical carcinoma with granulocytosis as a paraneoplastic syndrome, however, has been rarely reported. We recently witnessed a case of invasive squamous cell carcinoma of the uterine cervix with granulocytosis. Leukocytosis developed up to 69, 000/micro L, and then normalized after chemo-radiotherapy. There was no evidence of infection, tumor necrosis, glucocorticoid administration, or myeloproliferative disease by examination of a bone marrow aspirate when granulocytosis appeared. This phenomenon was probably associated with the secretion of hematopoietic growth factors such as G-CSF, GM-CSF and IL-6 by the tumor. We suggest that, like some other solid tumors, cervical cancer can present with granulocytosis as a paraneoplastic syndrome.
Uterine Neoplasms/complications/*diagnosis
;
Uterine Cervical Neoplasms/complications/*diagnosis/physiopathology
;
Paraneoplastic Syndromes/*etiology
;
Middle Aged
;
Leukocytosis/*etiology
;
Humans
;
Granulocytes/*pathology
;
Female